Лечащий Врач (Aug 2024)

Infrasound phonophoresis with peptide bioregulators and amino acids in children with epilepsy in partial optic atrophy

  • I. V. Sukhanova,
  • E. E. Sidorenko,
  • Yu. V. Taranova,
  • E. I. Sidorenko

DOI
https://doi.org/10.51793/OS.2024.27.7.007
Journal volume & issue
Vol. 0, no. 7
pp. 48 – 53

Abstract

Read online

Background. Approximately half of young children with seizures and increased convulsive readiness have postchiasmal visual disturbances. Congenital optic nerve atrophy is considered the most significant cause of blindness and visual impairment in children, especially premature infants. The diagnosis of epilepsy complicates the standard approach to the treatment of children with partial optic nerve atrophy. The choice of medical and physiotherapy treatment is limited. Therefore, we faced the question of the need to select modern gentle effective methods of complex treatment of patients in this group. To date, the methods of treatment of optic atrophy are aimed at improving blood circulation and metabolism of the retina and optic nerve, as well as at creating conditions that promote better conduction of neuronal excitation along the optic nerve fibers. The article describes the use of infrasonic phonophoresis with a complex of water-soluble polypeptide fractions of bovine retina, which has a stimulating effect on photoreceptors and cellular elements of the retina, improves functional interaction of pigment epithelium and outer segments of photoreceptors, glial cells in case of dystrophic changes, accelerates restoration of light sensitivity of the retina. The absence of complications and sufficiently high efficiency with more successful motor rehabilitation, improvement of intellectual abilities allow us to recommend this method of treatment to patients with epilepsy and partial atrophy of the optic nerve.Conclusion. A non-invasive complex treatment method using infrasound phonophoresis, pneumomassage using peptide bioregulators and amino acids has a significant effect, but does not cause psychological trauma to children, which makes it possible to use the proposed therapy as a method of choice in pediatric patients with descending partial optic nerve atrophy against the background of epilepsy and with a high risk of developing convulsive activity.

Keywords